The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naïve prostate cancer (mHNPC): ZZFIRST.
 
Joaquin Mateo
Consulting or Advisory Role - Amgen; AstraZeneca; MSD; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Guardant Health; Janssen; Pfizer
Research Funding - AstraZeneca (Inst); Pfizer
Travel, Accommodations, Expenses - AstraZeneca
 
Ángel Borque
Other Relationship - Astellas Pharma; AstraZeneca; Bayer; HealthMDx; Ipsen; Janssen; MSD; OPKO.; Palex
 
Daniel E. Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Pfizer; Roche
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst); Synlab (Inst)
Expert Testimony - Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Janssen; Roche
 
Miguel Angel A. Climent Duran
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bayer; Bristol-Myers Squibb; Celgene; Eisai; EUSA Pharma; Janssen Oncology; Janssen-Cilag; Merck; MSD Oncology; Pfizer; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; Pfizer; Roche
 
Albert Font
Consulting or Advisory Role - Astellas Pharma; Janssen; Sanofi
 
David Lorente
No Relationships to Disclose
 
Begona Mellado
No Relationships to Disclose
 
Alejo Rodriguez-Vida
No Relationships to Disclose
 
Merce Cuadras
No Relationships to Disclose
 
Jacques Planas
No Relationships to Disclose
 
Irene Casanova Salas
No Relationships to Disclose
 
Sarai Cordoba
No Relationships to Disclose
 
Lucila Gonzalez
No Relationships to Disclose
 
Marta Martínez de Falcon
Employment - MedSIR
 
Melissa Fernández
Employment - MedSIR
 
Miguel Sampayo-Cordero
Consulting or Advisory Role - Ability Pharma; Leti Pharma; MedSIR; Nestle health science; Syntax for Science
Speakers' Bureau - MedSIR; Roche
Research Funding - MedSIR; Vall d'Hebron University Hospital
 
Andrea Malfettone
Employment - MedSIR
 
Raquel Perez-Lopez
Consulting or Advisory Role - Roche
Speakers' Bureau - Pfizer; Roche
Research Funding - AstraZeneca/MedImmune; Roche
Travel, Accommodations, Expenses - AstraZeneca/MedImmune (Inst)
 
Joan Carles
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZéneca; Bayer; Bristol-Myers Squibb; Johnson & Johnson/Janssen; MSD Oncology; Pfizer; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Johnson & Johnson
Research Funding - AB Science (Inst); Aragon Pharmaceuticals (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Blueprint Medicines (Inst); BN ImmunoTherapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Cougar Biotechnology (Inst); Deciphera; Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen-Cilag International NV (Inst); Karyopharm Therapeutics (Inst); Laboratories Leurquin Mediolanum (Inst); Lilly (Inst); Medimmune (Inst); Millenium Pharamceuticals (Inst); Nanobiotix (Inst); Novartis Farmacéutica SA (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi Aventis GmbH (Inst); SFJ Pharmaceuticals Group (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS; Ipsen; Roche